Nurse Practitioner, Family · Cape Coral, FL
NPI
1831549765
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1528 del Prado Blvd S
Cape Coral, FL, 33990
Phone (239) 458-3338
Groups this clinician bills Medicare through
Medicare paid, 2024
$75K
3,059 services
Medicare patients, 2024
323
Average age 73
Drug cost, 2024
$2.7M
4,763 prescriptions
Company payments, 2025
$956
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dawn Russi was code 99214 (office e&m - established), 553 times for 263 patients. In total Dawn Russi billed 3,059 services in 31 codes, and Medicare paid $75K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 553 | 263 | $77.85 | $43K |
| 36415 Venipuncture Blood Collection | Office | 330 | 168 | $8.60 | $2,838 |
| 84443 Clinical Chemistry | Office | 307 | 160 | $16.36 | $5,022 |
| 80053 Clinical Chemistry | Office | 273 | 148 | $10.31 | $2,815 |
| 85025 Blood Count | Office | 237 | 126 | $7.61 | $1,804 |
| 83036 Blood Count | Office | 234 | 120 | $9.44 | $2,209 |
| 80061 Clinical Chemistry | Office | 223 | 115 | $13.00 | $2,900 |
| 82043 Clinical Chemistry | Office | 202 | 107 | $5.60 | $1,132 |
| 82570 Clinical Chemistry | Office | 201 | 106 | $5.03 | $1,011 |
| 84439 Clinical Chemistry | Office | 139 | 87 | $8.72 | $1,212 |
| 82607 Clinical Chemistry | Office | 104 | 76 | $14.64 | $1,522 |
| 84481 Clinical Chemistry | Office | 89 | 59 | $16.24 | $1,446 |
| 99213 Office E&M - Established | Office | 82 | 69 | $49.77 | $4,081 |
| 82306 Clinical Chemistry | Office | 24 | 19 | $27.90 | $670 |
| 99204 Office E&M - New | Office | 23 | 23 | $110.02 | $2,530 |
By year: 2022 $105K for 5,416 services; 2023 $94K for 3,898 services; 2024 $75K for 3,059 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 330 | 168 | $8.60 | $2,838 |
| 84443 Clinical Chemistry | 307 | 160 | $16.36 | $5,022 |
| 80053 Clinical Chemistry | 273 | 148 | $10.31 | $2,815 |
| 85025 Blood Count | 237 | 126 | $7.61 | $1,804 |
| 83036 Blood Count | 234 | 120 | $9.44 | $2,209 |
| 80061 Clinical Chemistry | 223 | 115 | $13.00 | $2,900 |
| 82043 Clinical Chemistry | 202 | 107 | $5.60 | $1,132 |
| 82570 Clinical Chemistry | 201 | 106 | $5.03 | $1,011 |
| 84439 Clinical Chemistry | 139 | 87 | $8.72 | $1,212 |
| 82607 Clinical Chemistry | 104 | 76 | $14.64 | $1,522 |
Medicare prescription drug claims, 2024
In 2024, the drug Dawn Russi prescribed most often to Medicare patients was Levothyroxine Sodium, with 584 prescriptions and refills. In total Dawn Russi wrote 4,763 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 584 | 1,692 | 168 | $5,280 |
| Ozempic Semaglutide | 349 | 592 | 82 | $565K |
| Metformin Hcl Generic | 323 | 957 | 99 | $2,083 |
| Jardiance Empagliflozin | 203 | 516 | 63 | $300K |
| Mounjaro Tirzepatide | 199 | 253 | 40 | $266K |
| Synthroid Levothyroxine Sodium | 163 | 432 | 43 | $14K |
| Glimepiride Generic | 144 | 418 | 41 | $1,101 |
| Glipizide Er Glipizide | 123 | 350 | 34 | $1,671 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 122 | 340 | 42 | $27K |
| Trulicity Dulaglutide | 122 | 196 | 26 | $195K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 96 | 263 | 45 | $12K |
| Atorvastatin Calcium Generic | 92 | 270 | 28 | $874 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 89 | 214 | 26 | $111K |
| Novolog Insulin Aspart | 86 | 221 | 27 | $39K |
| Metformin Hcl Er Metformin Hcl | 82 | 242 | 28 | $1,099 |
Brand drugs: 2,718 claims; generic drugs: 1,661 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dawn Russi $956 ($956 in general payments such as food, travel and fees) from 19 companies. The largest payer was Xeris Pharmaceuticals, Inc. with $128.
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 6 | $128 |
| Ascendis Pharma Endocrinology Inc ASND | 5 | $114 |
| Insulet Corporation PODD | 4 | $109 |
| Lilly USA, LLC LLY | 5 | $107 |
| Amgen Inc. AMGN | 3 | $55.25 |
| Almatica Pharma LLC | 3 | $51.69 |
| United Therapeutics Corporation UTHR | 2 | $50.67 |
| Tandem Diabetes Care, Inc. TNDM | 3 | $50.36 |
| Novo Nordisk Inc NVO | 2 | $43.07 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.